Publication:
Loss of poly (ADP-ribose) polymerase-2 leads to rapid development of spontaneous T-cell lymphomas in p53-deficient mice

Loading...
Thumbnail Image
Date
2010-02-15
relationships.isAuthorOfPublication
relationships.isSecondaryAuthorOf
relationships.isDirectorOf
Authors
Nicolás, L. ; Baró, C. ; Rodríguez, M. ; Baroja Mazo, A. ; Sole, F. ; Flores, J. M. ; Ampurdanés, C. ; Dantzer, Françoise ; Aparicio, P. ; Yélamos, J. ; Martínez Cáceres, Carlos Manuel
item.page.secondaryauthor
item.page.director
Publisher
Springer Nature
publication.page.editor
DOI
https://doi.org/10.1038/onc.2010.11
item.page.type
info:eu-repo/semantics/article
Description
© 2010, Macmillan Publishers Limited. This document is the Published version of a Published Work that appeared in final form in Oncogene. To access the final edited and published work see https://doi.org/10.1038/onc.2010.11
Abstract
Poly(ADP-ribose) polymerase-2 (Parp-2) belongs to a family of enzymes that catalyse poly(ADP-ribosyl)ation of proteins. Parp-2 deficiency in mice (Parp-2−/−) results in reduced thymic cellularity associated with increased apoptosis in thymocytes, defining Parp-2 as an important mediator of T-cell survival during thymopoiesis. To determine whether there is a link between Parp-2 and the p53 DNA-damage-dependent apoptotic response, we have generated Parp-2/p53-double-null mutant mice. We found that p53−/− backgrounds completely restored the survival and development of Parp-2−/− thymocytes. However, Parp-2-deficient thymocytes accumulated high levels of DNA double-strand breaks (DSB), independently of the p53 status, in line with a function of Parp-2 as a caretaker promoting genomic stability during thymocytes development. Although Parp-2−/− mice do not have spontaneous tumours, Parp-2 deficiency accelerated spontaneous tumour development in p53-null mice, mainly T-cell lymphomas. These data suggest a synergistic interaction between Parp-2 and p53 in tumour suppression through the role of Parp-2 in DNA-damage response and genome integrity surveillance, and point to the potential importance of examining human tumours for the status of both genes.
Citation
Oncogene, 2010, Vol. 29, pp. 2877–2883
item.page.embargo
Collections